Kuros

Kuros is a Swiss biotech firm that has shifted its focus entirely to the medtech sector. The company is aiming for substantial revenue growth by 2027, but its ambitious plans have raised skepticism among investors. Recent fluctuations in short positions reflect a mix of optimism about its operational growth and concerns regarding its ability to meet aggressive targets in a competitive market.